{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,8]],"date-time":"2026-11-08T03:46:26Z","timestamp":1794109586916,"version":"4.8.0"},"reference-count":49,"publisher":"Veterinary World","license":[{"start":{"date-parts":[[2023,3,26]],"date-time":"2023-03-26T00:00:00Z","timestamp":1679788800000},"content-version":"vor","delay-in-days":25,"URL":"https:\/\/www.veterinaryworld.org\/Vol.16\/March-2023\/24.pdf"}],"funder":[{"DOI":"10.13039\/501100017170","name":"Thailand Science Research and Innovation","doi-asserted-by":"publisher","award":["RTA6280011"],"award-info":[{"award-number":["RTA6280011"]}],"id":[{"id":"10.13039\/501100017170","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005621","name":"Kasetsart University Research and Development Institute","doi-asserted-by":"publisher","award":["FF(KU)17.64"],"award-info":[{"award-number":["FF(KU)17.64"]}],"id":[{"id":"10.13039\/501100005621","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vet World"],"published-print":{"date-parts":[[2023,3]]},"abstract":"<jats:p>Background and Aim: Feline infectious peritonitis (FIP), one of the most important infectious diseases in cats is caused by FIP virus (FIPV), a mutated variant of feline coronavirus. Feline infectious peritonitis has a negative impact on feline health, with extremely high mortality in clinical FIP-infected cats, particularly young cats. There are no approved drugs for FIP treatment, and therapeutic possibilities for FIP treatment are limited. This study aimed to utilize nature-derived bioactive flavonoids with antiviral properties to inhibit FIPV infection in Crandell\u2013Rees feline kidney (CRFK) cells.\n\nMaterials and Methods: The cytotoxicity of 16 flavonoids was evaluated on CRFK cells using a colorimetric method (MTS) assay. Viral kinetics of FIPV at 50 tissue culture infectious dose (TCID50)\/well was determined during the first 24-h post-infection (HPI). Antiviral activity was evaluated based on the replication steps of the virus life cycle, including pre-compound, attachment, penetration, post-viral entry, and virucidal assays. The antiviral efficacy of flavonoids against FIPV was determined based on positive FIPV-infected cells with the immunoperoxidase monolayer assay and viral load quantification using reverse transcription-quantitative polymerase chain reaction.\n\nResults: Two flavonoids, namely, isoginkgetin and luteolin, inhibited FIPV replication during post-viral entry in a dose-dependent manner, with 50% maximal effective concentrations = 4.77 \u00b1 0.09 and 36.28 \u00b1 0.03 \u03bcM, respectively. Based on viral kinetics, both flavonoids could inhibit FIPV replication at the early stage of infection at 0\u20136-HPI for isoginkgetin and 2\u20136-HPI for luteolin using a time-of-addition assay. Isoginkgetin exerted a direct virucidal effect that reduced the viral titers by 2 and 1.89 log10 TCID50\/mL at 60 and 120 min, respectively.\n\nConclusion: Isoginkgetin interfered with FIPV replication during both post-viral infection and virucidal experiments on CRFK cells, whereas luteolin inhibited the virus after infection. These results demonstrate the potential of herbal medicine for treating FIP.\n\nKeywords: antiviral, feline coronavirus, feline infectious peritonitis virus, flavonoids, infectious disease.<\/jats:p>","DOI":"10.14202\/vetworld.2023.618-630","type":"journal-article","created":{"date-parts":[[2023,3,26]],"date-time":"2023-03-26T08:36:24Z","timestamp":1679819784000},"page":"618-630","source":"Crossref","is-referenced-by-count":19,"title":["First study on in vitro antiviral and virucidal effects of flavonoids against feline infectious peritonitis virus at the early stage of infection"],"prefix":"10.14202","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-3770-6363","authenticated-orcid":false,"given":"Chanittha","family":"Triratapiban","sequence":"first","affiliation":[{"name":"Department of Microbiology and Immunology, Faculty of Veterinary Medicine, Kasetsart University, Bangkok 10900, Thailand."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-5953-976X","authenticated-orcid":false,"given":"Varanya","family":"Lueangaramkul","sequence":"additional","affiliation":[{"name":"Department of Microbiology and Immunology, Faculty of Veterinary Medicine, Kasetsart University, Bangkok 10900, Thailand."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-6542-6667","authenticated-orcid":false,"given":"Nantawan","family":"Phecharat","sequence":"additional","affiliation":[{"name":"Department of Microbiology and Immunology, Faculty of Veterinary Medicine, Kasetsart University, Bangkok 10900, Thailand."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-3764-0589","authenticated-orcid":false,"given":"Achiraya","family":"Pantanam","sequence":"additional","affiliation":[{"name":"Department of Microbiology and Immunology, Faculty of Veterinary Medicine, Kasetsart University, Bangkok 10900, Thailand."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5595-3296","authenticated-orcid":false,"given":"Porntippa","family":"Lekcharoensuk","sequence":"additional","affiliation":[{"name":"Department of Microbiology and Immunology, Faculty of Veterinary Medicine, Kasetsart University, Bangkok 10900, Thailand; Center for Advanced Studies in Agriculture and Food, Kasetsart University Institute for Advanced Studies, Kasetsart University, Bangkok 10900, Thailand."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6912-9764","authenticated-orcid":false,"given":"Sirin","family":"Theerawatanasirikul","sequence":"additional","affiliation":[{"name":"Department of Anatomy, Faculty of Veterinary Medicine, Kasetsart University, Bangkok 10900, Thailand."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"5308","published-online":{"date-parts":[[2023,3,26]]},"reference":[{"key":"ref0","doi-asserted-by":"publisher","unstructured":"1.\tPedersen, N.C. (2014) An update on feline infectious peritonitis: Virology and immunopathogenesis. Vet. J., 201(2): 123\u2013132.","DOI":"10.1016\/j.tvjl.2014.04.017"},{"key":"ref1","doi-asserted-by":"publisher","unstructured":"2.\tTekes, G. and Thiel, H.J. (2016) Feline coronaviruses: Pathogenesis of feline infectious peritonitis In Coronaviruses. Ziebuhr, J., editor. Advances in Virus Research. 1st edition. Cambridge: Elsevier.   193\u2013218.","DOI":"10.1016\/bs.aivir.2016.08.002"},{"key":"ref2","doi-asserted-by":"crossref","unstructured":"3.\tThayer, V., Gogolski, S., Felten, S., Hartmann, K., Kennedy, M. and Olah, G.A. (2022) 2022 AAFP\/every cat feline infectious peritonitis diagnosis guidelines. J. Feline Med. Surg., 24(9): 905\u2013933.","DOI":"10.1177\/1098612X221118761"},{"key":"ref3","doi-asserted-by":"crossref","unstructured":"4.\tKipar, A. and Meli, M.L. (2014) Feline infectious peritonitis: Still an enigma? Vet. Pathol., 51(2): 505\u2013526.","DOI":"10.1177\/0300985814522077"},{"key":"ref4","doi-asserted-by":"publisher","unstructured":"5.\tKim, Y., Shivanna, V., Narayanan, S., Prior, A.M., Weerasekara, S., Hua, D.H., Kankanamalage, A.C., Groutas, W.C. and Chang, K.O. (2015) Broad-spectrum inhibitors against 3C-like proteases of feline coronaviruses and feline caliciviruses. J. Virol., 89(9): 4942\u20134950.","DOI":"10.1128\/jvi.03688-14"},{"key":"ref5","doi-asserted-by":"crossref","unstructured":"6.\tPedersen, N.C., Kim, Y., Liu, H., Galasiti Kankanamalage, A.C., Eckstrand, C., Groutas, W.C., Bannasch, M., Meadows, J.M. and Chang, K.O. (2018) Efficacy of a 3C-like protease inhibitor in treating various forms of acquired feline infectious peritonitis. J. Feline Med. Surg., 20(4): 378\u2013392.","DOI":"10.1177\/1098612X17729626"},{"key":"ref6","doi-asserted-by":"publisher","unstructured":"7.\tDickinson, P.J., Bannasch, M., Thomasy, S.M., Murthy, V.D., Vernau, K.M., Liepnieks, M., Montgomery, E., Knickelbein, K.E., Murphy, B. and Pedersen, N.C. (2020) Antiviral treatment using the adenosine nucleoside analogue GS-441524 in cats with clinically diagnosed neurological feline infectious peritonitis. J. Vet. Intern. Med., 34(4): 1587\u20131593.","DOI":"10.1111\/jvim.15780"},{"key":"ref7","doi-asserted-by":"publisher","unstructured":"8.\tPedersen, N.C., Perron, M., Bannasch, M., Montgomery, E., Murakami, E., Liepnieks, M. and Liu, H. (2019) Efficacy and safety of the nucleoside analog GS-441524 for treatment of cats with naturally occurring feline infectious peritonitis. J. Feline Med. Surg., 21(4): 271\u2013281.","DOI":"10.1177\/1098612x19825701"},{"key":"ref8","doi-asserted-by":"publisher","unstructured":"9.\tJones, S., Novicoff, W., Nadeau, J. and Evans, S. (2021) Unlicensed GS-441524-like antiviral therapy can be effective for at-home treatment of feline infectious peritonitis. Animals, 11(8): 2257.","DOI":"10.3390\/ani11082257"},{"key":"ref9","doi-asserted-by":"publisher","unstructured":"10.\tIzes, A.M., Yu, J., Norris, J.M. and Govendir, M. (2020) Current status on treatment options for feline infectious peritonitis and SARS-CoV-2 positive cats. Vet. Q., 41(1): 322\u2013330.","DOI":"10.1080\/01652176.2020.1845917"},{"key":"ref10","doi-asserted-by":"publisher","unstructured":"11.\tAgostini, M.L., Andres, E.L., Sims, A.C., Graham, R.L., Sheahan, T.P., Lu, X., Smith, E.C., Case, J.B., Feng, J.Y., Jordan, R., Ray, A.S., Cihlar, T., Siegel, D., Mackman, R.L., Clarke, M.O., Baric, R.S. and Denison, M.R. (2018) Coronavirus susceptibility to the antiviral remdesivir (GS-5734) is mediated by the viral polymerase and the proofreading exoribonuclease. mBio, 9(2): e00221\u201318.","DOI":"10.1128\/mbio.00221-18"},{"key":"ref11","doi-asserted-by":"crossref","unstructured":"12.\tCamero, M., Lanave, G., Catella, C., Lucente, M.S., Sposato, A., Mari, V., Tempesta, M., Martella, V. and Buonavoglia, A. (2022) ERDRP-0519 inhibits feline coronavirus in vitro. BMC Vet. Res., 18(1): 55.","DOI":"10.1186\/s12917-022-03153-3"},{"key":"ref12","doi-asserted-by":"publisher","unstructured":"13.\tMcDonagh, P., Sheehy, P.A. and Norris, J.M. (2014) Identification and characterisation of small molecule inhibitors of feline coronavirus replication. Vet. Microbiol., 174(3\u20134): 438\u2013447.","DOI":"10.1016\/j.vetmic.2014.10.030"},{"key":"ref13","doi-asserted-by":"publisher","unstructured":"14.\tKameshima, S., Kimura, Y., Doki, T., Takano, T., Park, C.H. and Itoh, N. (2020) Clinical efficacy of combination therapy of itraconazole and prednisolone for treating effusive feline infectious peritonitis. J. Vet. Med. Sci., 82(10): 1492\u20131496.","DOI":"10.1292\/jvms.20-0049"},{"key":"ref14","doi-asserted-by":"publisher","unstructured":"15.\tBadshah, S.L., Faisal, S., Muhammad, A., Poulson, B.G., Emwas, A.H. and Jaremko, M. (2021) Antiviral activities of flavonoids. Biomed. Pharmacother., 140 : 111596.","DOI":"10.1016\/j.biopha.2021.111596"},{"key":"ref15","doi-asserted-by":"publisher","unstructured":"16.\tZakaryan, H., Arabyan, E., Oo, A. and Zandi, K. (2017) Flavonoids: Promising natural compounds against viral infections. Arch. Virol., 162(9): 2539\u20132551.","DOI":"10.1007\/s00705-017-3417-y"},{"key":"ref16","doi-asserted-by":"publisher","unstructured":"17.\tTheerawatanasirikul, S., Kuo, C.J., Phetcharat, N. and Lekcharoensuk, P. (2020) In silico and in vitro analysis of small molecules and natural compounds targeting the 3CL protease of feline infectious peritonitis virus. Antiviral Res., 174 : 104697.","DOI":"10.1016\/j.antiviral.2019.104697"},{"key":"ref17","doi-asserted-by":"publisher","unstructured":"18.\tTheerawatanasirikul, S., Kuo, C.J., Phecharat, N., Chootip, J., Lekcharoensuk, C. and Lekcharoensuk, P. (2020) Structural-based virtual screening and in vitro assays for small molecules inhibiting the feline coronavirus 3CL protease as a surrogate platform for coronaviruses. Antiviral Res., 182 : 104927.","DOI":"10.1016\/j.antiviral.2020.104927"},{"key":"ref18","doi-asserted-by":"publisher","unstructured":"19.\tReed, L.J. and Muench, H. (1938) A simple method of estimating fifty percent endpoints. Am. J. Epidemiol., 27(3): 493\u2013497.","DOI":"10.1093\/oxfordjournals.aje.a118408"},{"key":"ref19","doi-asserted-by":"publisher","unstructured":"20.\tXu, X., Miao, J., Shao, Q., Gao, Y. and Hong, L. (2020) Apigenin suppresses influenza A virus-induced RIG-I activation and viral replication. J. Med. Virol., 92(12): 3057\u20133066.","DOI":"10.1002\/jmv.26403"},{"key":"ref20","doi-asserted-by":"crossref","unstructured":"21.\tMoghaddam, E., Teoh, B.T., Sam, S.S., Lani, R., Hassandarvish, P., Chik, Z., Yueh, A., Abubakar, S. and Zandi, K. (2014) Baicalin, a metabolite of baicalein with antiviral activity against dengue virus. Sci. Rep., 4(1): 5452.","DOI":"10.1038\/srep05452"},{"key":"ref21","doi-asserted-by":"publisher","unstructured":"22.\tZandi, K., Musall, K., Oo, A., Cao, D., Liang, B., Hassandarvish, P., Lan, S., Slack, R.L., Kirby, K.A., Bassit, L., Amblard, F., Kim, B., Abubakar, S., Sarafianos, S.G. and Schinazi, R.F. (2021) Baicalein and baicalin inhibit SARS-CoV-2 RNA-dependent-RNA polymerase. Microorganisms, 9(5): 893\u2013903.","DOI":"10.3390\/microorganisms9050893"},{"key":"ref22","doi-asserted-by":"publisher","unstructured":"23.\tYang, F., Feng, C., Yao, Y., Qin, A., Shao, H. and Qian, K. (2020) Antiviral effect of baicalin on Marek\u2019s disease virus in CEF cells. BMC Vet. Res., 16(1): 371.","DOI":"10.21203\/rs.3.rs-31533\/v1"},{"key":"ref23","doi-asserted-by":"publisher","unstructured":"24.\tArabyan, E., Hakobyan, A., Hakobyan, T., Grigoryan, R., Izmailyan, R., Avetisyan, A., Karalyan, Z., Jackman, J.A., Ferreira, F., Elrod, C.C. and Zakaryan, H. (2021) Flavonoid library screening reveals kaempferol as a potential antiviral agent against African swine fever virus. Front. Microbiol., 12 :736780.","DOI":"10.3389\/fmicb.2021.736780"},{"key":"ref24","doi-asserted-by":"publisher","unstructured":"25.\tChen, Y., Zeng, L., Lu, Y., Yang, Y., Xu, M., Wang, Y. and Liu, J. (2017) Treatment effect of a flavonoid prescription on duck virus hepatitis by its hepatoprotective and antioxidative ability. Pharm. Biol., 55(1): 198\u2013205.","DOI":"10.1080\/13880209.2016.1255977"},{"key":"ref25","doi-asserted-by":"publisher","unstructured":"26.\tYan, H., Ma, L., Wang, H., Wu, S., Huang, H., Gu, Z., Jiang, J. and Li, Y. (2019) Luteolin decreases the yield of influenza A virus in vitro by interfering with the coat protein I complex expression. J. Nat. Med., 73(3): 487\u2013496.","DOI":"10.1007\/s11418-019-01287-7"},{"key":"ref26","doi-asserted-by":"crossref","unstructured":"27.\tWang, S., Ling, Y., Yao, Y., Zheng, G. and Chen, W. (2020) Luteolin inhibits respiratory syncytial virus replication by regulating the MiR-155\/SOCS1\/STAT1 signaling pathway. Virol. J., 17(1): 187.","DOI":"10.1186\/s12985-020-01451-6"},{"key":"ref27","doi-asserted-by":"publisher","unstructured":"28.\tMunaf\u00f2, F., Donati, E., Brindani, N., Ottonello, G., Armirotti, A. and De Vivo, M. (2022) Quercetin and luteolin are single-digit micromolar inhibitors of the SARS-CoV-2 RNA-dependent RNA polymerase. Sci. Rep., 12(1): 10571.","DOI":"10.1038\/s41598-022-14664-2"},{"key":"ref28","doi-asserted-by":"publisher","unstructured":"29.\tDong, W., Wei, X., Zhang, F., Hao, J., Huang, F., Zhang, C. and Liang, W. (2014) A dual character of flavonoids in influenza A virus replication and spread through modulating cell-autonomous immunity by MAPK signaling pathways. Sci. Rep., 4(1): 7237.","DOI":"10.1038\/srep07237"},{"key":"ref29","doi-asserted-by":"publisher","unstructured":"30.\tHaridas, M., Sasidhar, V., Nath, P., Abhithaj, J., Sabu, A. and Rammanohar, P. (2021) Compounds of Citrus medica and Zingiber officinale for COVID-19 inhibition: In silico evidence for cues from Ayurveda. Futur. J. Pharm. Sci., 7(1): 13.","DOI":"10.1186\/s43094-020-00171-6"},{"key":"ref30","doi-asserted-by":"publisher","unstructured":"31.\tHuynh, T., Wang, H. and Luan, B. (2020) Structure-based lead optimization of herbal medicine rutin for inhibiting SARS-CoV-2\u2019s main protease. Phys. Chem. Chem. Phys., 22(43): 25335\u201325343.","DOI":"10.1039\/d0cp03867a"},{"key":"ref31","doi-asserted-by":"publisher","unstructured":"32.\tSchwarz, S., Sauter, D., Wang, K., Zhang, R., Sun, B., Karioti, A., Bilia, A.R., Efferth, T. and Schwarz, W. (2014) Kaempferol derivatives as antiviral drugs against the 3a channel protein of coronavirus. Planta Med., 80(2\u20133): 177\u2013182.","DOI":"10.1055\/s-0033-1360277"},{"key":"ref32","doi-asserted-by":"publisher","unstructured":"33.\tYin, D., Li, J., Lei, X., Liu, Y., Yang, Z. and Chen, K. (2014) Antiviral activity of total flavonoid extracts from Selaginella moellendorffii Hieron against coxsackie virus B3 in vitro and in vivo. Evid\/ Based Complement. Altern. Med., 2014 : 950817.","DOI":"10.1155\/2014\/950817"},{"key":"ref33","doi-asserted-by":"publisher","unstructured":"34.\tLi, F., Song, X., Su, G., Wang, Y., Wang, Z., Jia, J., Qing, S., Huang, L., Wang, Y., Zheng, K. and Wang, Y. (2019) Amentoflavone inhibits HSV-1 and ACV-resistant strain infection by suppressing early viral infection. Viruses, 11(5): 466\u2013482.","DOI":"10.3390\/v11050466"},{"key":"ref34","doi-asserted-by":"publisher","unstructured":"35.\tTheerawatanasirikul, S., Thangthamniyom, N., Kuo, C.J., Semkum, P., Phecharat, N., Chankeeree, P. and Lekcharoensuk, P. (2021) Natural phytochemicals, luteolin and isoginkgetin, inhibit 3C protease and infection of FMDV, in silico and in vitro. Viruses, 13(11): 2118.","DOI":"10.3390\/v13112118"},{"key":"ref35","doi-asserted-by":"crossref","unstructured":"36.\tRaj, V., Lee, J., Shim, J. and Lee, J. (2022) Antiviral activities of 4H-chromen-4-one scaffold-containing flavonoids against SARS-CoV-2 using computational and in vitro approaches. J. Mol. Liq., 353 : 118775.","DOI":"10.1016\/j.molliq.2022.118775"},{"key":"ref36","doi-asserted-by":"publisher","unstructured":"37.\tWang, H.X., Zeng, M.S., Ye, Y., Liu, J.Y. and Xu, P.P. (2021) Antiviral activity of puerarin as a potent inhibitor of influenza virus neuraminidase. Phyther. Res., 35(1): 324\u2013336.","DOI":"10.1002\/ptr.6803"},{"key":"ref37","doi-asserted-by":"publisher","unstructured":"38.\tCarneiro, B.M., Batista, M.N., Braga, A.S., Nogueira, M.L. and Rahal, P. (2016) The green tea molecule EGCG inhibits zika virus entry. Virology, 496 : 215\u2013218.","DOI":"10.1016\/j.virol.2016.06.012"},{"key":"ref38","doi-asserted-by":"publisher","unstructured":"39.\tLai, Y.H., Sun, C.P., Huang, H.C., Chen, J.C., Liu, H.K. and Huang, C. (2018) Epigallocatechin gallate inhibits hepatitis B virus infection in human liver chimeric mice. BMC Complement. Altern. Med., 18(1): 248.","DOI":"10.1186\/s12906-018-2316-4"},{"key":"ref39","doi-asserted-by":"publisher","unstructured":"40.\tJang, M., Park, Y.I., Cha, Y.E., Park, R., Namkoong, S., Lee, J.I. and Park, J. (2020) Tea polyphenols EGCG and theaflavin inhibit the activity of SARS-CoV-2 3CL-protease in vitro. Evidence-based Complement. Altern. Med., 2020 : 5630838.","DOI":"10.1155\/2020\/5630838"},{"key":"ref40","doi-asserted-by":"publisher","unstructured":"41.\tLyu, S.Y., Rhim, J.Y. and Park, W.B. (2005) Antiherpetic activities of flavonoids against herpes simplex virus Type 1 (HSV-1) and Type 2 (HSV-2) in vitro. Arch. Pharm. Res., 28(11): 1293\u20131301.","DOI":"10.1007\/bf02978215"},{"key":"ref41","doi-asserted-by":"publisher","unstructured":"42.\tHo, H.Y., Cheng, M.L., Weng, S.F., Leu, Y.L. and Chiu, D.T.Y. (2009) Antiviral effect of epigallocatechin gallate on enterovirus 71. J. Agric. Food Chem., 57(14): 6140\u20136147.","DOI":"10.1021\/jf901128u"},{"key":"ref42","doi-asserted-by":"publisher","unstructured":"43.\tLi, S., Hattori, T. and Kodama, E.N. (2011) Epigallocatechin gallate inhibits the HIV reverse transcription step. Antivir. Chem. Chemother., 21(6): 239\u2013243.","DOI":"10.3851\/imp1774"},{"key":"ref43","doi-asserted-by":"publisher","unstructured":"44.\tO\u2019Brien, K., Matlin, A.J., Lowell, A.M. and Moore, M.J. (2008) The biflavonoid isoginkgetin is a general inhibitor of pre-mRNA splicing. J. Biol. Chem., 283(48): 33147\u201333154.","DOI":"10.1074\/jbc.m805556200"},{"key":"ref44","doi-asserted-by":"publisher","unstructured":"45.\tYoon, S.O., Shin, S., Lee, H.J., Chun, H.K. and Chung, A.S. (2006) Isoginkgetin inhibits tumor cell invasion by regulating phosphatidylinositol 3-kinase\/Akt-dependent matrix metalloproteinase-9 expression. Mol. Cancer Ther., 5(11): 2666\u20132675.","DOI":"10.1158\/1535-7163.mct-06-0321"},{"key":"ref45","doi-asserted-by":"publisher","unstructured":"46.\tTsalikis, J., Abdel-Nour, M., Farahvash, A., Sorbara, M.T., Poon, S., Philpott, D.J. and Girardin, S.E. (2019) Isoginkgetin, a natural biflavonoid proteasome inhibitor, sensitizes cancer cells to apoptosis via disruption of lysosomal homeostasis and impaired protein clearance. Mol. Cell. Biol., 39(10): e00489\u201318.","DOI":"10.1128\/mcb.00489-18"},{"key":"ref46","doi-asserted-by":"publisher","unstructured":"47.\tDey, D., Hossain, R., Biswas, P., Paul, P., Islam, M.A., Ema, T.I., Gain, B.K., Hasan, M.M., Bibi, S., Islam, M.T., Rahman, M.A. and Kim, B. (2022) Amentoflavone derivatives significantly act towards the main protease (3CLpro\/Mpro) of SARS-CoV-2: in silico ADMET profiling, molecular docking, molecular dynamics simulation, network pharmacology. Mol. Divers . 1\u201315.","DOI":"10.1007\/s11030-022-10459-9"},{"key":"ref47","doi-asserted-by":"publisher","unstructured":"48.\tWilsky, S., Sobotta, K., Wiesener, N., Pilas, J., Althof, N., Munder, T., Wutzler, P. and Henke, A. (2012) Inhibition of fatty acid synthase by amentoflavone reduces coxsackievirus B3 replication. Arch. Virol., 157(2): 259\u2013269.","DOI":"10.1007\/s00705-011-1164-z"},{"key":"ref48","doi-asserted-by":"crossref","unstructured":"49.\tRoy, M., Jacque, N., Novicoff, W., Li, E., Negash, R. and Evans, S.J.M. (2022) Unlicensed Molnupiravir is an effective rescue treatment following failure of unlicensed GS-441524-like therapy for cats with suspected feline infectious peritonitis. Pathogens, 11(10): 1209.","DOI":"10.3390\/pathogens11101209"}],"container-title":["Veterinary World"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.veterinaryworld.org\/Vol.16\/March-2023\/24.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,26]],"date-time":"2023-03-26T11:26:05Z","timestamp":1679829965000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.veterinaryworld.org\/Vol.16\/March-2023\/24.html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":49,"URL":"https:\/\/doi.org\/10.14202\/vetworld.2023.618-630","relation":{},"ISSN":["2231-0916","0972-8988"],"issn-type":[{"value":"2231-0916","type":"electronic"},{"value":"0972-8988","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3]]}}}